Press Releases

ALISO VIEJO, Calif., Oct. 1, 2019 /PRNewswire/ -- Ambry Genetics®&nbs

FORT LAUDERDALE, Fla., Oct. 1, 2019 /PRNewswire/ -- Delphi Behavioral Health Group, a leading nationwide provider of addiction and detox treatment programs, announced toda

RESEARCH TRIANGLE PARK, N.C., Oct. 1, 2019 /PRNewswire/ -- Marken announced today that six Marken branches will become Cell and Gene Centers of Excellence in 2019. In addition, a full-time, global team has been appointed to develop and support the products and services required to handle cell, gene and immunotherapy materials

WALTHAM, Mass., Oct. 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed its previously announced acquisition of an active pharmaceutical ingredient (API) manufacturing facility from GlaxoSmithKline (GSK) for €90 million. Completion of the transaction follows the receipt of all required regulator

SARATOGA SPRINGS, N.Y., Oct. 1, 2019 /PRNewswire/ -- Saratoga Hospital is leasing more than 56,000 square feet at Wilton Mall to free much-needed space for patient care on the main hospital campus.

OAK RIDGE, Tenn., Oct. 1, 2019 /PRNewswire/ -- AllMeds, the leading provider of cutting-edge EHR, Practice Manager and RCM/Billing & Collection solutions to specialty practices across the United States, today announced the launch of its Chronic Care Management (CCM) partnership with HealthWatch™. Practices using CCM from Al

WASHINGTON, Oct. 1, 2019 /PRNewswire/ -- A new collaborative effort of four major professional counseling organizations aimed at improving access to quality mental health care nationwide has resulted in a proposed uniform portability plan called the – National Counselor Licensure Endorsement Process - or "NCLEP 2.0."

INDIANAPOLIS, Oct. 1, 2019 /PRNewswire/ -- iSalus Healthcare, creators of ENTChoiceTM, have nearly 20 years of experience in the healthcare technology industry.  Built specifically for Otolaryngology Providers in the United States, ENTChoiceTM removes the excess information that physicians in this field do not n

SAN DIEGO, Oct. 1, 2019 /PRNewswire/ -- Molecular Assemblies, Inc., today announced that it has raised a $12.2 million Series A financing led

TOKYO, Oct. 1, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced it will invest nearly $13 million into two innovation incubators operated by LabCentral, a premier United States-based laboratory